Enterprise for Research and Advocacy to Stop and Eradicate HIV
We are a new collaboratory that is focused on curing HIV through innovative immunological approaches and the education of HIV community members and researchers through multi-platform engagement.
WHAT IS OUR MISSION?
Sign Up for Updates
We have assembled a research team of world leaders in T cell biology and HIV pathogenesis who are working at the forefront of HIV cure. We have partnered with an advocacy team who have been leading the fight for HIV education and reproductive justice for over 30 years.
We aim to deliver community supported therapeutics that disrupt the underlying mechanisms of HIV persistence that will result in sustained viral remission and ultimately eradication of the rebound competent viral reservoir.
Characterization of pro-latency and cytotoxic CD8 T cell functions for successful post-treatment control and latent reservoir eradication of HIV-1.
Immune based strategies to induce host immune responses able to intercept and control the rebounding virus
Modulation of CD8+ T cell pro-latency activity to effectively induce “shock and suicide” to eradicate the latent reservoir.
SisterLove Inc. (SLI) is the oldest women-centered HIV and sexual/reproductive health, rights and justice organization in the Southeastern US. Founded in 1989 in Atlanta, Georgia, they are dedicated to the HIV-related intersections of education, prevention, research, support and human rights advocacy needs of women and girls, and their families. SisterLove Inc. celebrates 31 years of building a legacy as a community-based leader, advocate and educator of evidence-based prevention options for women, including biomedical, behavioral, social and structural interventions.